Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ales Tomek

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
International Journal of Cardiology|April 30, 2016
Missed bleeding events after ticagrelor in PEGASUS trial: Massive non-compliance, information censoring, or both?Victor Serebruany, Ales Tomek
International Journal of Cardiology|October 15, 2013
Misrepresentation of vital status follow-up: challenging the integrity of the PLATO trial and the claimed mortality benefit of ticagrelor versus clopidogrelJames J DiNicolantonio, Ales Tomek
International Journal of Cardiology|August 6, 2013
Inactivations, deletions, non-adjudications, and downgrades of clinical endpoints on ticagrelor: serious concerns over the reliability of the PLATO trialJames J DiNicolantonio, Ales Tomek
The American Journal of Cardiology|July 20, 2015
Survival After Solid Cancers in Antithrombotic TrialsVictor L Serebruany, Ales Tomek, Moo Hyun Kim
International Journal of Cardiology|June 4, 2013
Refuting the ticagrelor-aspirin black box warning: and proposing a ticagrelor early-PCI black box warningJames J DiNicolantonio, Victor L Serebruany, Ales Tomek
American Journal of Therapeutics|March 26, 2010
Optimization of anticoagulation with warfarin for stroke prevention: pharmacogenetic considerationsAles Tomek, Vaclav Matoska, Christian Eisert, et al.
Topics in Companion Animal Medicine|May 8, 2021
Clinical Presentation, Diagnostic Findings, and Long-term Survival Time in 182 Dogs With Meningoencephalitis of Unknown Origin From Central Europe That Were Administered Glucocorticosteroid MonotherapyTereza Kosinová Paušová, Ales Tomek, Petr Šrenk, et al.
International Journal of Cardiology|June 5, 2015
Among antithrombotic agents, prasugrel, but not ticagrelor, is associated with reduced 30 day mortality in patients with ST-elevated myocardial infarctionVictor L Serebruany, Vasily Cherepanov, Ales Tomek, et al.
Journal of Feline Medicine and Surgery|April 8, 2006
Intracranial neoplasia in 61 cats: localisation, tumour types and seizure patternsAles Tomek, Sigitas Cizinauskas, Marcus Doherr, et al.
Expert Review of Cardiovascular Therapy|October 30, 2015
Clopidogrel, prasugrel, ticagrelor or vorapaxar in patients with renal impairment: do we have a winner?Victor L Serebruany, Ales Tomek, Alex N Pokov, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
International Journal of Cardiology|April 30, 2016
Missed bleeding events after ticagrelor in PEGASUS trial: Massive non-compliance, information censoring, or both?Victor Serebruany, Ales Tomek
International Journal of Cardiology|October 15, 2013
Misrepresentation of vital status follow-up: challenging the integrity of the PLATO trial and the claimed mortality benefit of ticagrelor versus clopidogrelJames J DiNicolantonio, Ales Tomek
International Journal of Cardiology|August 6, 2013
Inactivations, deletions, non-adjudications, and downgrades of clinical endpoints on ticagrelor: serious concerns over the reliability of the PLATO trialJames J DiNicolantonio, Ales Tomek
The American Journal of Cardiology|July 20, 2015
Survival After Solid Cancers in Antithrombotic TrialsVictor L Serebruany, Ales Tomek, Moo Hyun Kim
International Journal of Cardiology|June 4, 2013
Refuting the ticagrelor-aspirin black box warning: and proposing a ticagrelor early-PCI black box warningJames J DiNicolantonio, Victor L Serebruany, Ales Tomek
American Journal of Therapeutics|March 26, 2010
Optimization of anticoagulation with warfarin for stroke prevention: pharmacogenetic considerationsAles Tomek, Vaclav Matoska, Christian Eisert, et al.
Topics in Companion Animal Medicine|May 8, 2021
Clinical Presentation, Diagnostic Findings, and Long-term Survival Time in 182 Dogs With Meningoencephalitis of Unknown Origin From Central Europe That Were Administered Glucocorticosteroid MonotherapyTereza Kosinová Paušová, Ales Tomek, Petr Šrenk, et al.
International Journal of Cardiology|June 5, 2015
Among antithrombotic agents, prasugrel, but not ticagrelor, is associated with reduced 30 day mortality in patients with ST-elevated myocardial infarctionVictor L Serebruany, Vasily Cherepanov, Ales Tomek, et al.
Journal of Feline Medicine and Surgery|April 8, 2006
Intracranial neoplasia in 61 cats: localisation, tumour types and seizure patternsAles Tomek, Sigitas Cizinauskas, Marcus Doherr, et al.
Expert Review of Cardiovascular Therapy|October 30, 2015
Clopidogrel, prasugrel, ticagrelor or vorapaxar in patients with renal impairment: do we have a winner?Victor L Serebruany, Ales Tomek, Alex N Pokov, et al.
Pageof 4